Australia Reschedules Psilocybin and MDMA to Begin Treating TRD and PTSD
Policy
Good news from the Australian Therapeutic Goods Administration, as they will now allow for the prescription of MDMA to treat post-traumatic stress disorder (PTSD), and psilocybin to combat treatment-resistant depression. This new classification is a step forward in providing relief with alternative treatments that have been proven effective.
Leave a Reply
Want to join the discussion?Feel free to contribute!